Photobiomodulation Therapy for Tnraumatic Brain Injury

Farzad Salehpour, Saeed Sadigh-Eteghad, Javad Mahmoudi, Farzin Kamari, Paolo Cassano, Michael Richard Hamblin

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


This chapter explores the potential of photobiomodulation (PBM) therapy for traumatic brain injury (TBI), providing an overview of the condition, discussing relevant animal models, and examining the therapeutic approach in both animal studies and human clinical trials. Section 1 introduces traumatic brain injury, a significant cause of death and disability worldwide. The chapter discusses acute and chronic TBI (1.1) and various animal models of TBI (1.2) that play a crucial role in advancing our understanding of the disorder’s underlying mechanisms and testing potential therapeutic interventions, such as PBM. Section 2 focuses on PBM therapy for TBI, with subsections discussing its application in animal models (2.1) and human studies (2.2). This section offers a comprehensive overview of the current state of research, emphasizing the potential benefits of PBM therapy in promoting neuroprotection for traumatic brain injury.

Original languageEnglish
Title of host publicationSynthesis Lectures on Biomedical Engineering
PublisherSpringer Nature
Number of pages24
Publication statusPublished - 2023

Publication series

NameSynthesis Lectures on Biomedical Engineering
VolumePart F1286
ISSN (Print)1930-0328
ISSN (Electronic)1930-0336

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biochemistry
  • Biomedical Engineering


Dive into the research topics of 'Photobiomodulation Therapy for Tnraumatic Brain Injury'. Together they form a unique fingerprint.

Cite this